11-66521254-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBS2_Supporting
The NM_024649.5(BBS1):c.724-16C>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000575 in 1,602,014 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Consequence
NM_024649.5 splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BBS1 | NM_024649.5 | c.724-16C>T | splice_polypyrimidine_tract_variant, intron_variant | ENST00000318312.12 | |||
ZDHHC24 | NM_001348571.2 | c.*234G>A | 3_prime_UTR_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BBS1 | ENST00000318312.12 | c.724-16C>T | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_024649.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000801 AC: 122AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000410 AC: 103AN: 251344Hom.: 0 AF XY: 0.000456 AC XY: 62AN XY: 135856
GnomAD4 exome AF: 0.000551 AC: 799AN: 1449680Hom.: 2 Cov.: 27 AF XY: 0.000514 AC XY: 371AN XY: 722006
GnomAD4 genome AF: 0.000801 AC: 122AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000792 AC XY: 59AN XY: 74480
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 20, 2024 | - - |
Bardet-Biedl syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at